• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,100.47 109.25
( 0.14%)
Global Indices
Nasdaq
51,927.61 57.71
(0.11%)
Dow Jones
7,374.18 -5.04
(-0.07%)
Hang Seng
69,065.93 -3,300.41
(-4.56%)
Nikkei 225
10,536.79 75.16
(0.72%)
Forex
USD-INR
94.55 -0.19
(-0.20%)
EUR-INR
107.36 -0.64
(-0.59%)
GBP-INR
124.56 -0.65
(-0.52%)
JPY-INR
0.58 0.00
(-0.30%)

EQUITY - MARKET SCREENER

Foseco Crucible (India) Ltd
Industry :  Refractories / Intermediates
BSE Code
ISIN Demat
Book Value()
523160
INE599F01020
250.2857143
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
26.24
772.66
EPS(TTM)
Face Value()
Div & Yield %
52.59
5
0.91
 

piramal capital & housing finance ltd
Rossari Biotech consolidated net profit rises 33.48% in the March 2026 quarter
Apr 28,2026
Net profit of Rossari Biotech rose 33.48% to Rs 45.97 crore in the quarter ended March 2026 as against Rs 34.44 crore during the previous quarter ended March 2025. Sales rose 18.17% to Rs 684.86 crore in the quarter ended March 2026 as against Rs 579.56 crore during the previous quarter ended March 2025.

For the full year,net profit rose 9.41% to Rs 149.21 crore in the year ended March 2026 as against Rs 136.38 crore during the previous year ended March 2025. Sales rose 15.19% to Rs 2396.37 crore in the year ended March 2026 as against Rs 2080.29 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales684.86579.56 18 2396.372080.29 15
OPM %11.2811.99 -11.9312.74 -
PBDT87.7765.93 33 281.64252.26 12
PBT64.2447.71 35 202.52185.19 9
NP45.9734.44 33 149.21136.38 9